Dr Danika Hill

@precisionvaxlab.bsky.social

Immunologist interested in T cells, B cells, antibodies, vaccines & global health. #StrepA #malaria Lab Head @MonashImmunol @MonashUni She/Her https://research.monash.edu/en/persons/danika-hill

My lab is recruiting! To coincide with my relocation to WEHI in July, I’m recruiting for two Research Officer (Postdoc) positions. Both roles will be involved in advancing development of vaccines and therapeutics for Streptococcus pyogenes. Please spread the word! 📣 See 🧵for details 👇

Bild

Congrats @linterman.bsky.social @smguillaume.bsky.social and team for this nice study about B cells fighting on the front lines (the 🫁)

Michelle Linterman@linterman.bsky.social · last yr.

Great to have our paper out in @pnas.org showing that lung B cells in ectopic germinal centers undergo affinity maturation. @smguillaume.bsky.social @wsfoster.bsky.social @sanmarti92.bsky.social @emae-watson.bsky.social Silvia Innocentin, Grant Kennedy & Alice Denton. doi.org/10.1073/pnas...

I’m so excited to be a chief investigator for this $10M Wellcome Trust grant, and for all the important things we’re going to learn about immunity against Strep A with researchers spanning three continents.

Josh Osowicki@joshosowicki.bsky.social · last yr.

A terrific postscript! Exciting @wellcometrust.bsky.social funded #StrepA work, with Ed Clarke, Hannah Frost, @precisionvaxlab.bsky.social, @njmoreland.bsky.social, @thushan-desilva.bsky.social, Penda Johm, Ya Jankey-Jagne, @drmichaelmarks.bsky.social, David Khoury, Andrew Steer.

Really important #ImmunoSky findings from @jenjuno.viralvaxlab.com and co-authors about the pitfalls of using activation markers to detect antigen-specific T cells. Good news is they’ve found a marker combination that gets rid of bystander activated cells! Check out the preprint and 🧵 below 👀

Jennifer Juno@jenjuno.viralvaxlab.com · 2y ago

As a first #ImmunoSky post, I’m excited to share our latest pre-print, by the fantastic Mitchell Zheng! www.biorxiv.org/content/10.1... Our group is interested in virus-specific CD4 T cells, which means we often use in vitro stimulations (like the AIM assay) to find our cells of interest. 🧵 1/9

8/9 In short, we suggest in vitro stimulation activates ag-specific T cells, which secrete cytokines and activate Treg and Th17/22 cells. Without careful phenotyping, all of these cells can get picked up as AIM+, accounting for the Th17-like memory cells found in many virus-specific AIM datasets.

Bild

Finally jumping into 🦋 - and what better way to do than highlighting this super thread. Wonderful to have been involved in this study with our Strep A friends across the Tasman

Dr Danika Hill@precisionvaxlab.bsky.social · 2y ago

🎉 I'm a #newPI , and I'm so excited to share our new paper out in Nature Comms today! 🧵 rdcu.be/d2gBV Quick intro for the new followers: I'm from Monash Uni in Melbourne, and we study T and B cell responses to viruses, bacteria & parasites with the goal of improving vaccines. #ImmunoSky #MicroSky

Today I had a collaborator say “I never share my findings with anyone before they’re published. I’ve been burnt before”. It’s got me wondering how widespread ‘getting burnt’ is in science. 🤔 #ImmunoSky I’m keen to hear horror stories and what impact it had on your approach to science!!

My X feed is mostly gun violence and pro-Trump nonsense. Time for a radical change! Hoping to find the twitter community I’ve lost. I’m interested in all things immunology, but particularly adaptive immune responses to vaccines and infectious disease. Bring on bluer skies!